| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
146,072 |
135,274 |
$7.01M |
| 80053 |
Comprehensive metabolic panel |
62,296 |
54,622 |
$5.36M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
17,251 |
16,481 |
$3.42M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,885 |
6,994 |
$3.24M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
33,581 |
28,414 |
$2.62M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
44,083 |
42,351 |
$2.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
80,060 |
71,257 |
$1.95M |
| 87081 |
|
21,661 |
21,125 |
$1.66M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,108 |
3,941 |
$1.50M |
| 36415 |
Collection of venous blood by venipuncture |
7,291 |
6,947 |
$1.33M |
| 87275 |
|
26,574 |
25,690 |
$1.31M |
| 81001 |
|
68,763 |
62,441 |
$1.25M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,947 |
4,114 |
$1.23M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,124 |
3,842 |
$837K |
| 71046 |
Radiologic examination, chest; 2 views |
20,799 |
19,886 |
$718K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,445 |
3,092 |
$682K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,326 |
19,430 |
$673K |
| 87210 |
|
6,808 |
6,537 |
$599K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16,034 |
15,271 |
$548K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,870 |
4,325 |
$528K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19,829 |
18,811 |
$527K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,912 |
8,374 |
$492K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
44,939 |
39,931 |
$470K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,373 |
2,162 |
$413K |
| 81025 |
|
41,698 |
38,665 |
$396K |
| 12001 |
|
2,111 |
2,059 |
$371K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,299 |
3,256 |
$368K |
| 81002 |
|
2,904 |
2,583 |
$355K |
| 12011 |
|
1,821 |
1,782 |
$353K |
| 71045 |
Radiologic examination, chest; single view |
30,400 |
27,588 |
$330K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
34,019 |
28,100 |
$326K |
| 10060 |
|
1,897 |
1,807 |
$313K |
| 73610 |
|
4,089 |
3,938 |
$309K |
| 74018 |
|
4,033 |
3,862 |
$306K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,467 |
13,779 |
$304K |
| 73562 |
|
5,405 |
5,201 |
$303K |
| 73130 |
|
4,060 |
3,914 |
$298K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12,109 |
11,500 |
$295K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,708 |
2,615 |
$290K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,902 |
9,550 |
$275K |
| 73630 |
|
4,784 |
4,596 |
$272K |
| 82565 |
|
1,423 |
1,191 |
$263K |
| J3490 |
Unclassified drugs |
2,206 |
1,977 |
$249K |
| 84702 |
|
6,169 |
5,286 |
$249K |
| 84112 |
|
1,060 |
996 |
$247K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,208 |
1,509 |
$236K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,467 |
1,378 |
$232K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
828 |
794 |
$220K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,330 |
4,139 |
$206K |
| 73030 |
|
3,867 |
3,680 |
$195K |
| 73140 |
|
1,842 |
1,792 |
$195K |
| 76801 |
|
3,488 |
3,202 |
$178K |
| 73110 |
|
2,841 |
2,742 |
$175K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,179 |
1,152 |
$171K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,607 |
4,408 |
$170K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,748 |
5,465 |
$169K |
| 85027 |
|
97,750 |
80,896 |
$168K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
20,556 |
20,032 |
$167K |
| 72100 |
|
4,125 |
4,005 |
$165K |
| 84484 |
|
27,924 |
22,811 |
$164K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14,234 |
12,647 |
$155K |
| 74019 |
|
2,592 |
2,519 |
$151K |
| 87070 |
|
1,794 |
1,688 |
$150K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,741 |
1,681 |
$145K |
| 76825 |
|
845 |
815 |
$143K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,994 |
3,951 |
$136K |
| 76642 |
|
1,741 |
1,702 |
$121K |
| 87420 |
|
3,963 |
3,800 |
$117K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
119 |
108 |
$111K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,554 |
2,482 |
$110K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,743 |
3,637 |
$110K |
| 87077 |
|
4,290 |
4,096 |
$110K |
| 93971 |
|
2,582 |
2,468 |
$108K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,733 |
4,969 |
$106K |
| 72050 |
|
1,490 |
1,457 |
$105K |
| 12002 |
|
712 |
691 |
$99K |
| 73080 |
|
1,887 |
1,812 |
$98K |
| 76830 |
Ultrasound, transvaginal |
1,715 |
1,639 |
$96K |
| 80047 |
|
1,183 |
1,089 |
$95K |
| 77066 |
Tomosynthesis, mammo |
1,024 |
1,003 |
$95K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,504 |
4,308 |
$93K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,144 |
919 |
$91K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
10,818 |
10,321 |
$91K |
| 76820 |
|
1,790 |
780 |
$91K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,405 |
1,291 |
$90K |
| 73090 |
|
1,744 |
1,647 |
$87K |
| 15853 |
|
228 |
216 |
$86K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
685 |
674 |
$82K |
| 73502 |
|
1,801 |
1,727 |
$73K |
| 72072 |
|
1,592 |
1,546 |
$72K |
| G0378 |
Hospital observation service, per hour |
8,822 |
5,981 |
$70K |
| 76770 |
|
939 |
905 |
$69K |
| 73590 |
|
1,773 |
1,647 |
$66K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19,056 |
16,495 |
$63K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
39,639 |
34,339 |
$60K |
| 80076 |
|
1,997 |
1,946 |
$59K |
| 81003 |
|
4,255 |
4,067 |
$58K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
17,865 |
15,781 |
$57K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,330 |
2,243 |
$57K |
| 29125 |
|
925 |
903 |
$56K |
| 84703 |
|
8,282 |
7,883 |
$52K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
455 |
445 |
$51K |
| 16020 |
|
661 |
462 |
$50K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,953 |
1,910 |
$50K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
396 |
291 |
$44K |
| 82731 |
|
225 |
210 |
$44K |
| 71250 |
|
501 |
471 |
$43K |
| 86850 |
|
3,319 |
3,105 |
$42K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
279 |
272 |
$40K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,649 |
8,382 |
$38K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
425 |
416 |
$37K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,925 |
3,772 |
$36K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
24,040 |
20,672 |
$35K |
| 77336 |
|
403 |
142 |
$35K |
| 99152 |
|
819 |
745 |
$35K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,991 |
8,711 |
$34K |
| 70486 |
|
1,225 |
1,195 |
$32K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
42,550 |
24,601 |
$32K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,158 |
4,689 |
$32K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,520 |
8,333 |
$27K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
174 |
167 |
$26K |
| 93970 |
|
605 |
578 |
$26K |
| 72131 |
|
741 |
719 |
$24K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,520 |
913 |
$24K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20,389 |
15,848 |
$23K |
| 71101 |
|
367 |
349 |
$23K |
| 82247 |
|
1,224 |
846 |
$22K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
102 |
97 |
$22K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,315 |
1,297 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,697 |
5,479 |
$20K |
| 77065 |
Tomosynthesis, mammo |
565 |
504 |
$19K |
| 83880 |
|
6,818 |
6,201 |
$19K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
7,174 |
5,894 |
$18K |
| 85007 |
|
774 |
756 |
$17K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,297 |
1,238 |
$17K |
| 80061 |
Lipid panel |
5,095 |
4,944 |
$16K |
| 70360 |
|
161 |
160 |
$16K |
| 72040 |
|
188 |
183 |
$16K |
| 73660 |
|
161 |
154 |
$15K |
| A9270 |
Non-covered item or service |
11,323 |
3,368 |
$15K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,172 |
1,426 |
$15K |
| 82607 |
|
1,041 |
1,026 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,809 |
5,026 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,285 |
6,062 |
$12K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,541 |
863 |
$12K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,967 |
3,419 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
14 |
13 |
$12K |
| 70496 |
|
642 |
612 |
$12K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,827 |
1,036 |
$12K |
| 36600 |
|
142 |
135 |
$11K |
| 84439 |
|
3,097 |
2,990 |
$11K |
| 73552 |
|
323 |
311 |
$10K |
| 88304 |
|
1,371 |
1,338 |
$10K |
| 97161 |
|
587 |
580 |
$10K |
| 83605 |
|
4,697 |
4,160 |
$9K |
| 82570 |
|
1,085 |
974 |
$9K |
| 83690 |
|
21,781 |
19,906 |
$9K |
| 86140 |
|
1,779 |
1,679 |
$9K |
| 70498 |
|
741 |
702 |
$9K |
| 85379 |
|
5,380 |
5,179 |
$9K |
| C1769 |
Guide wire |
1,132 |
1,002 |
$9K |
| 84156 |
|
967 |
833 |
$9K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,019 |
775 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,528 |
4,060 |
$8K |
| 73060 |
|
227 |
217 |
$8K |
| 88307 |
|
596 |
577 |
$8K |
| 82270 |
|
112 |
106 |
$8K |
| 76870 |
|
143 |
132 |
$8K |
| 74174 |
|
124 |
118 |
$8K |
| 97162 |
|
1,025 |
987 |
$8K |
| 96376 |
|
3,131 |
2,664 |
$8K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,384 |
3,049 |
$7K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
4,150 |
3,881 |
$7K |
| 82728 |
|
1,118 |
1,098 |
$7K |
| 86592 |
|
173 |
171 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
3,588 |
3,062 |
$7K |
| 86900 |
|
5,508 |
5,112 |
$7K |
| 85610 |
|
7,999 |
7,306 |
$7K |
| 73600 |
|
111 |
108 |
$7K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
185 |
157 |
$6K |
| 70491 |
|
269 |
260 |
$6K |
| 93922 |
|
25 |
25 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
104 |
98 |
$6K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
894 |
687 |
$6K |
| 93017 |
|
521 |
507 |
$6K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
94 |
91 |
$6K |
| 29515 |
|
149 |
145 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
3,815 |
2,064 |
$5K |
| J1953 |
Injection, levetiracetam, 10 mg |
173 |
144 |
$5K |
| 74022 |
|
253 |
251 |
$5K |
| 84100 |
|
3,169 |
2,291 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29 |
28 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
13 |
$5K |
| 74246 |
|
93 |
92 |
$4K |
| 97116 |
|
184 |
119 |
$4K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
387 |
161 |
$4K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
530 |
475 |
$4K |
| 87186 |
|
4,139 |
3,940 |
$4K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
463 |
453 |
$4K |
| 69200 |
|
24 |
24 |
$4K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
119 |
118 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
2,710 |
2,455 |
$3K |
| 73620 |
|
57 |
50 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
518 |
470 |
$3K |
| 82330 |
|
246 |
238 |
$3K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,632 |
1,299 |
$3K |
| 73560 |
|
79 |
72 |
$3K |
| J0456 |
Injection, azithromycin, 500 mg |
105 |
99 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
47 |
46 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,989 |
2,996 |
$2K |
| 00731 |
|
444 |
436 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
12 |
$2K |
| 83735 |
|
12,421 |
9,911 |
$2K |
| 86308 |
|
78 |
75 |
$2K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,999 |
1,930 |
$2K |
| 87276 |
|
26,576 |
25,692 |
$2K |
| C9113 |
Injection, pantoprazole sodium, per vial |
79 |
60 |
$2K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
10,378 |
9,941 |
$2K |
| 86141 |
|
254 |
252 |
$2K |
| 86780 |
|
103 |
100 |
$2K |
| 72170 |
|
58 |
55 |
$2K |
| 82784 |
|
164 |
158 |
$2K |
| 83540 |
|
1,015 |
993 |
$2K |
| 85018 |
|
1,282 |
1,036 |
$2K |
| 80164 |
|
478 |
412 |
$2K |
| 97166 |
|
222 |
210 |
$2K |
| 87040 |
|
4,023 |
3,400 |
$2K |
| 72128 |
|
38 |
38 |
$1K |
| 86701 |
|
65 |
64 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,796 |
9,446 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
174 |
173 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
117 |
78 |
$1K |
| 85014 |
|
862 |
706 |
$1K |
| 11045 |
|
1,807 |
557 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
84 |
79 |
$1K |
| 93325 |
|
951 |
919 |
$1K |
| 85046 |
|
1,367 |
906 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
19 |
12 |
$1K |
| 86703 |
|
268 |
265 |
$1K |
| 82803 |
|
399 |
351 |
$1K |
| 77080 |
|
12 |
12 |
$972.40 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
252 |
223 |
$966.93 |
| 97597 |
|
263 |
186 |
$916.12 |
| 36000 |
|
325 |
319 |
$892.46 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,747 |
3,500 |
$859.85 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
88 |
61 |
$801.60 |
| 82150 |
|
445 |
429 |
$754.35 |
| 11043 |
|
39 |
26 |
$673.30 |
| 85730 |
|
6,125 |
5,654 |
$669.38 |
| 82950 |
|
27 |
27 |
$619.64 |
| 83655 |
|
42 |
41 |
$614.05 |
| 82248 |
|
2,352 |
2,031 |
$593.69 |
| 97165 |
|
56 |
54 |
$552.55 |
| 90714 |
|
2,601 |
2,526 |
$550.98 |
| 87147 |
|
2,973 |
2,845 |
$509.31 |
| 86038 |
|
13 |
13 |
$454.00 |
| 87205 |
|
2,425 |
2,241 |
$452.86 |
| 84550 |
|
575 |
527 |
$418.59 |
| 84132 |
|
269 |
244 |
$349.81 |
| 85651 |
|
2,193 |
2,083 |
$322.82 |
| 83993 |
|
26 |
25 |
$318.89 |
| 73521 |
|
12 |
12 |
$308.86 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,823 |
1,623 |
$297.16 |
| 82746 |
|
142 |
142 |
$252.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,719 |
2,296 |
$236.64 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
585 |
561 |
$226.11 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,268 |
2,070 |
$189.01 |
| 00840 |
|
366 |
362 |
$171.24 |
| 82550 |
|
2,282 |
2,130 |
$170.69 |
| 94644 |
|
202 |
197 |
$131.72 |
| 88302 |
|
12 |
12 |
$113.84 |
| 99153 |
Mod sedat endo service >5yrs |
322 |
290 |
$80.85 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
871 |
771 |
$68.91 |
| 86901 |
|
5,500 |
5,105 |
$68.12 |
| 94664 |
|
147 |
142 |
$51.56 |
| 86803 |
|
13 |
12 |
$39.73 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
770 |
622 |
$24.16 |
| 86920 |
|
188 |
160 |
$24.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
130 |
122 |
$15.64 |
| 82553 |
|
318 |
306 |
$14.39 |
| J3480 |
Injection, potassium chloride, per 2 meq |
338 |
298 |
$1.98 |
| 90686 |
|
13 |
13 |
$0.00 |
| 88342 |
|
551 |
536 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
243 |
230 |
$0.00 |
| 84153 |
|
13 |
13 |
$0.00 |
| 86762 |
|
30 |
30 |
$0.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
35 |
24 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
123 |
103 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
367 |
338 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
17 |
12 |
$0.00 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
18 |
14 |
$0.00 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
20 |
14 |
$0.00 |
| 83921 |
|
24 |
24 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
41 |
41 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
131 |
119 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
27 |
26 |
$0.00 |
| 87340 |
|
76 |
76 |
$0.00 |
| 00790 |
|
42 |
41 |
$0.00 |
| 00813 |
|
51 |
51 |
$0.00 |
| Q4100 |
Skin substitute, not otherwise specified |
26 |
24 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
53 |
52 |
$0.00 |
| 86364 |
|
38 |
38 |
$0.00 |
| 82043 |
|
12 |
12 |
$0.00 |
| 36430 |
|
20 |
13 |
$0.00 |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
14 |
12 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
20 |
17 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
502 |
318 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
150 |
131 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
251 |
175 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
60 |
56 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
381 |
362 |
$0.00 |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
155 |
142 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
131 |
106 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
40 |
29 |
$0.00 |
| S5000 |
Prescription drug, generic |
14 |
14 |
$0.00 |
| 84450 |
|
56 |
52 |
$0.00 |
| C1758 |
Catheter, ureteral |
12 |
12 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
96 |
96 |
$0.00 |
| 47562 |
|
28 |
28 |
$0.00 |
| 84460 |
|
57 |
53 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
79 |
68 |
$0.00 |
| 83516 |
|
68 |
68 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
91 |
78 |
$0.00 |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
12 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
29 |
27 |
$0.00 |
| 82010 |
|
38 |
37 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
14 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
183 |
110 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
17 |
17 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$0.00 |
| 83970 |
|
13 |
12 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
15 |
12 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
15 |
12 |
$0.00 |
| 0042T |
|
12 |
12 |
$0.00 |